Catechol

Catechol

SCHEMBL7624422

Oc1cc2cc[nH]c2cc1O.Oc1ccccc1O

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.50
TYR P14679 1/20 0.50
USP2 O75604 1/20 0.50
GAA P10253 1/20 0.50
RAD51 Q06609 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
GPR84 Q9NQS5 1/20 0.47
AHR P35869 7/20 0.46
CA2 P00918 2/20 0.46
CA4 P22748 2/20 0.46
TRPA1 O75762 1/20 0.46
CA1 P00915 1/20 0.46
ITGB2 P05107 1/20 0.46
ICAM1 P05362 1/20 0.46
ITGAL P20701 1/20 0.46
CA6 P23280 1/20 0.46
ADK P55263 1/20 0.46
NPC1 O15118 2/20 0.46
MAOA P21397 2/20 0.45
MAOB P27338 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28298713 0.91 TYR (0.58) ALOX15TYRUSP2GAARAD51
SCHEMBL31375351 0.91 TYR (0.58) ALOX15TYRUSP2GAARAD51
SCHEMBL48994 0.91 TYR (0.58) ALOX15TYRUSP2GAARAD51
SCHEMBL31375356 0.91 TYR (0.58) ALOX15TYRUSP2GAARAD51
Bromide SCHEMBL27546379 0.89 TYR (0.56) ALOX15TYRUSP2GAARAD51
Bromide SCHEMBL29769307 0.89 TYR (0.56) ALOX15TYRUSP2GAARAD51
Hydrochloric Acid SCHEMBL4625112 0.89 TYR (0.56) ALOX15TYRUSP2GAARAD51
SCHEMBL5464095 0.83 KDM4E (0.43) ALOX15TYRUSP2GAARAD51
Bicarbonate SCHEMBL4385266 0.83 ENPP2 (0.53) ALOX15TYRUSP2GAARAD51
Sulfuric Acid SCHEMBL9312939 0.82 TYR (0.48) ALOX15TYRUSP2GAARAD51

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6440691-B1 AIDS VIRICIDES LARGE SCALE BIOLOGY CORPORATION 2002-08-27 US disclosed
US-20020039726-A1 Melanins with improved ability to inhibit HIV replication GARGER STEVEN (US) 2002-04-04 US disclosed
US-6300057-B1 TREATING HIV INFECTIONS BY ADMINISTERING A THERAPEUTIC DOSE OF SYNTHESIZED MELANIN CONTAINING AN ANIONIC GROUP OF SULFATES AND SULFONYLS; NONTOXIC THERAPY OF HUMAN IMMUNODEFICIENCY VIRUS LARGE SCALE BIOLOGY CORPORATION 2001-10-09 US disclosed
EP-1096021-A2 Melanins with improved ability to inhibit HIV replication Biosource Technologies, Inc. (US) 2001-05-02 EP disclosed
EP-1095652-A2 Melanins with improved ability to inhibit HIV replication Biosource Technologies, Inc. (US) 2001-05-02 EP disclosed
US-5801047-A Method for making stable extracellular tyrosinase and synthesis of polyphenolic polymers therefrom BIOSOURCE TECHNOLOGIES, INC. (US) 1998-09-01 US disclosed
US-5792649-A IN VITRO CULTURE MEDIUM CONTAINING MICROORGANISM EXPRESSING TYROSINASE HAVING ACTIVITY STABILIZED BY A REDUCED CONCENTRATION OF DISSOLVED OXYGEN IN THE MEDIUM BIOSOURCE TECHNOLOGIES, INC. (US) 1998-08-11 US disclosed
US-5486351-A MELANINS BIOSOURCE TECHNOLOGIES, INC. (US) 1996-01-23 US disclosed
US-5466592-A Method for making stable, extracellular tyrosinase and synthesis of polyphenolic polymers therefrom BIOSOURCE TECHNOLOGIES, INC. (US) 1995-11-14 US disclosed
EP-0672148-A1 METHOD FOR MAKING STABLE, EXTRACELLULAR TYROSINASE AND SYNTHESIS OF POLYPHENOLIC POLYMERS THEREFROM Biosource Technologies, Inc. (US) 1995-09-20 EP disclosed
US-5340734-A In vitro biosynthesis the melanins in presence of a substrate consisting of tyrosine binding single amino acid, a dipeptide or an oligopeptide BIOSOURCE GENETICS CORPORATION (US) 1994-08-23 US disclosed
WO-1994012644-A2 METHOD FOR MAKING STABLE, EXTRACELLULAR TYROSINASE AND SYNTHESIS OF POLYPHENOLIC POLYMERS THEREFROM BIOSOURCE GENETICS CORPORATION (US) 1994-06-09 WO disclosed